All CME Activities

  • Congenital Heart Disease in Pulmonary Arterial Hypertension

    Course Image: 
    Credit type: 
    Physician
    Credit Hours: 
    1.00
    Activity Release Date: 
    Feb 3 2012
    Activity Expiration Date: 
    Oct 31 2013

    Dr. Usha Krishnan presents this which describes the role of pulmonary arterial hypertension in congenital heart disease patients as well as the management of disease both before and following surgery.  Some of the specific examples of CHD include the identification and treatment options for Eisenmenger Syndrome as well ass the role increased pulmonary resistance in the failing fontan.

  • Pulmonary Arterial Hypertension in Systemic Sclerosis: Characteristics and Diagnosis

    Credit type: 
    Physician
    Credit Hours: 
    0.75
    Activity Release Date: 
    Feb 2 2012
    Activity Expiration Date: 
    Oct 31 2013

    Dr. Silver presents this course which will discuss the diagnosis of pulmonary arterial hypertension in systemic sclerosis.  This includes an overview of scleroderma and the classification criteria as well as predominant subtypes in scleroderma as well as a look at the causes of PAH in scleroderma patients.

  • Emerging Pharmacological Treatment Approaches/Novel Pathways: Strengths, Gaps, Unmet Needs

    Course Image: 
    Credit type: 
    Physician
    Credit Hours: 
    0.75
    Activity Release Date: 
    Jan 19 2012
    Activity Expiration Date: 
    Sep 1 2012

    Dr. Robyn Barst discusses the future of pulmonary hypertension therapies in this presentation from the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference.  From tyrosine kinase inhibitors to inhaled nitrous oxide and the many opportunites for treatment currently under research.

  • Update on Eisenmenger Syndrome: The Role of Specific Pulmonary Hypertension Therapies

    Course Image: 
    Credit type: 
    Physician
    Credit Hours: 
    0.50
    Activity Release Date: 
    Jan 19 2012
    Activity Expiration Date: 
    Sep 1 2012

    Dr. Gary Webb gave this update on Eisenmenger Syndromes and the specific therapies related to pulmonary hypertension at the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference.  This presentation covers the definition and causes of Eisenmenger syndrome as well as issues involved with pulmonary artery banding.

  • Pulmonary Hypertension Associated with Hemolytic Disorders

    Course Image: 
    Credit type: 
    Physician
    Credit Hours: 
    0.75
    Activity Release Date: 
    Jan 19 2012
    Activity Expiration Date: 
    Sep 1 2012

    At the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conferece, Mark Gladwin, MD presented this lecture on the different hemolytic conditions seen in pulmonary hypertension. This includes the way that hemolytic conditions may affect nitric oxide signaling and the impact on survival.

  • Pulmonary Hypertension on the Indian Subcontinent

    Course Image: 
    Credit type: 
    Physician
    Credit Hours: 
    0.50
    Activity Release Date: 
    Jan 19 2012
    Activity Expiration Date: 
    Sep 1 2012

    At the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference, S. Ramakrishnan, MD, DM, AIIMS presented this lecture about the state of pulmonary hypertension in India, a country that has a vastly underdiagnosed population of patients suffering from congenital heart disease.  He discusses how the general barriers to effective health care play out in the field of pulmonary hypertension.

  • Chronic Thromboembolic Pulmonary Hypertension

    Course Image: 
    Credit type: 
    Physician
    Credit Hours: 
    0.50
    Activity Release Date: 
    Oct 5 2011
    Activity Expiration Date: 
    Sep 1 2012

    Stuart Jamieson, MB, FRCS, MD gave this presentation on Chronic Thromboembolic Pulmonary Hypertension (CTEPH) at the 4th Annual International Neonatal and Childhood Pulmonary Vascular Disease Conference.  This presentation discussing the keys to diagnosis as well as the incidence and prevelance of this under recognized condition.  Dr. Jamiesen also discusses the classification of operative specimens as well as the specifics of dealing with pulmonary endarterectomy.Course Author

     

     

  • Persistent Pulmonary Hypertension of the Newborn: Radical Thoughts About Oxygen

    Course Image: 
    Credit type: 
    Physician
    Credit Hours: 
    0.75
    Activity Release Date: 
    Oct 5 2011
    Activity Expiration Date: 
    Sep 1 2012

    Robin H. Steinhorn, MD presented this session at the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference.  Dr. Steinhorn also discusses the current goals of oxygen therapy and new ideas about the continued use of oxygen therapy. This presentation describes the effects of elevated FiO2 on vascular structure and reactivity as well as the pathways of generation and signaling reactive oxygen species.

    Filed in:

  • Endothelial Progenitor Cells and Chronic Neonatal Pulmonary Hypertension

    Course Image: 
    Credit type: 
    Physician
    Credit Hours: 
    0.50
    Activity Release Date: 
    Oct 5 2011
    Activity Expiration Date: 
    Sep 1 2012

    Bernard Thebaud, MD presented this session at the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference.  Dr. Thebaud discusses the role of angiogenesis in lung development.  This session also focuses on emerging cell based theropies using vacular progenitor cells for pulmonary hypertension therapies. 

  • Genetics of Pulmonary Hypertension

    Course Image: 
    Credit type: 
    Physician
    Credit Hours: 
    0.75
    Activity Release Date: 
    Oct 5 2011
    Activity Expiration Date: 
    Sep 1 2012

    As part of the preceedings at the 4th Annual International Neonatal and Childhood Pulmonary Vascular Disease Conference, Nicholas Morrell presented this session on the genetic involvement in hereditary pulmonary hypertension.  Dr. Morrell discusses how the expression of the BMPR2 mutation affects the physiological progression of pulmonary hypertension.